Watch Videos Online

Mylan CEO on FDA-approved biosimilar, Trumps drug price plan



CBS This Morning News-Politics 2018-06-12 - 13:13:04

"Nearly two years after taking tremendous heat for the rising cost of EpiPens, pharmaceutical giant Mylan is making strides in the fast-growing biosimilar market. Biosimilars are drugs and devices made to be similar to already-approved products, potentially lowering the cost of treatment. Mylan won FDA approval last week for a biosimilar drug designed to help some cancer patients reduce infection risk during chemotherapy. Mylan CEO Heather Bresch joins CBS This Morning to explain how biosimilars could translate to patient savings, what the company learned from the EpiPen debacle, and why she applauds President Trumps plan to reduce drug costs. Subscribe to the CBS This Morning Channel HERE: http://bit.ly/1Q0v2hE Watch CBS This Morning HERE: http://bit.ly/1T88yAR Watch the latest installment of Note to Self, only on CBS This Morning, HERE: http://cbsn.ws/1Sh8XlB Follow CBS This Morning on Instagram HERE: http://bit.ly/1Q7NGnY Like CBS This Morning on Facebook HERE: http://on.fb.me/1LhtdvI Follow CBS This Morning on Twitter HERE: http://bit.ly/1Xj5W3p Follow CBS This Morning on Google+ HERE: http://bit.ly/1SIM4I8 Get the latest news and best in original reporting from CBS News delivered to your inbox. Subscribe to newsletters HERE: http://cbsn.ws/1RqHw7T Get your news on the go! Download CBS News mobile apps HERE: http://cbsn.ws/1Xb1WC8 Get new episodes of shows you love across devices the next day, stream local news live, and watch full seasons of CBS fan favorites anytime, anywhere with CBS All Access. Try it free! http://bit.ly/1OQA29B Delivered by Norah O’Donnell and Gayle King, CBS This Morning offers a thoughtful, substantive and insightful source of news and information to a daily audience of 3 million viewers. The Emmy Award-winning broadcast presents a mix of daily news, coverage of developing stories of national and global significance, and interviews with leading figures in politics, business and entertainment. Check local listings for CBS This Morning broadcast times."



Sign up to our newsletter

Don't miss any trending posts!